Document:

Exhibit 4.9

 

THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS
OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED
UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE
ISSUER, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.

 

WARRANT TO PURCHASE STOCK

 

Company: Everyday Health, Inc.,
a Delaware corporation

Number of Shares: 183,254, subject
to adjustment

Type/Series of Stock: Common Stock,
$0.01 par value per share

Warrant Price: $0.01 per Share,
subject to adjustment

Issue Date: October 22, 2012

Expiration Date: October 21, 2022
See also Section 5.1(b).

Credit Facility: This Warrant
to Purchase Stock (“Warrant”) is issued in connection with that certain Subordinated Loan and Security
Agreement of even date herewith among Silicon Valley Bank, Silver Lake Waterman Fund, L.P., the Company, Everyday Health Media,
LLC and MedPage Today, L.L.C. (as amended and/or modified and in effect from time to time, the “Loan Agreement”)
and the participation therein of WestRiver Mezzanine Loans, LLC pursuant to an arrangement among Silicon Valley Bank, WestRiver
Management, LLC and WestRiver Mezzanine Loans, LLC.

 

THIS WARRANT CERTIFIES
THAT, for good and valuable consideration, WESTRIVER MEZZANINE LOANS, LLC (together with any successor or permitted assignee or
transferee of this Warrant or of any shares issued upon exercise hereof, “Holder”) is entitled to purchase
the number of fully paid and non-assessable shares (the “Shares”) of the above-stated Type/Series of Stock
(the “Class”) of the above-named company (the “Company”) at the above-stated Warrant
Price, all as set forth above and as adjusted pursuant to Section 2 of this Warrant, subject to the provisions and upon the terms
and conditions set forth in this Warrant.

 

SECTION 1. EXERCISE.

 

1.1 Method of Exercise.
Holder may at any time and from time to time exercise this Warrant, in whole or in part, by delivering to the Company the original
of this Warrant together with a duly executed Notice of Exercise in substantially the form attached hereto as Appendix 1 and, unless
Holder is exercising this Warrant pursuant to a cashless exercise set forth in Section 1.2, a check, wire transfer of same-day
funds (to an account designated by the Company), or other form of payment acceptable to the Company for the aggregate Warrant Price
for the Shares being purchased.

 

1.2 Cashless Exercise.
On any exercise of this Warrant, in lieu of payment of the aggregate Warrant Price in the manner as specified in Section 1.1 above,
but otherwise in accordance with the requirements of Section 1.1, Holder may elect to receive Shares equal to the value of this
Warrant, or portion hereof as to which this Warrant is being exercised. Thereupon, the Company shall issue to the Holder such number
of fully paid and non-assessable Shares as are computed using the following formula:

    	 

    	

    

	 	X = Y(A-B)/A

 

where:

 

	 	X =	the number of Shares to be issued to the Holder;
	 	 	 
	 	Y =	the number of Shares with respect to which this Warrant is being exercised (inclusive of the Shares surrendered to the Company in payment of the aggregate Warrant Price);
	 	 	 
	 	A =	the Fair Market Value (as determined pursuant to Section 1.3 below) of one Share; and
	 	 	 
	 	B =	the Warrant Price.

 

1.3 Fair Market Value.
If shares of the Class are then traded or quoted on a nationally recognized securities exchange, inter-dealer quotation system
or over-the-counter market (a “Trading Market”), the fair market value of a Share shall be the closing
price or last sale price of a share of the Class reported for the Business Day immediately before the date on which Holder delivers
this Warrant together with its Notice of Exercise to the Company. If shares of the Class are not then traded in a Trading Market,
the Board of Directors of the Company shall determine the fair market value of a Share in its reasonable good faith judgment.

 

1.4 Delivery of Certificate
and New Warrant. Within a reasonable time after Holder exercises this Warrant in the manner set forth in Section 1.1 or 1.2
above, the Company shall deliver to Holder a certificate representing the Shares issued to Holder upon such exercise and, if this
Warrant has not been fully exercised and has not expired, a new warrant of like tenor representing the Shares not so acquired.

 

1.5 Replacement of
Warrant. On receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this
Warrant and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in form,
substance and amount to the Company or, in the case of mutilation, on surrender of this Warrant to the Company for cancellation,
the Company shall, within a reasonable time, execute and deliver to Holder, in lieu of this Warrant, a new warrant of like tenor
and amount.

 

1.6 Treatment of
Warrant Upon Acquisition of Company.

 

(a) Acquisition.
For the purpose of this Warrant, “Acquisition” means any transaction or series of related transactions
involving: (i) the sale, lease, exclusive license, or other disposition of all or substantially all of the assets of the Company
(ii) any merger or consolidation of the Company into or with another person or entity (other than a merger or consolidation effected
exclusively to change the Company’s domicile), or any other corporate reorganization, in which the stockholders of the Company
in their capacity as such immediately prior to such merger, consolidation or reorganization, own less than a majority of the Company’s
(or the surviving or successor entity’s) outstanding voting power immediately after such merger, consolidation or reorganization
(or, if such Company stockholders beneficially own a majority of the outstanding voting power of the surviving or successor entity
as of immediately after such merger, consolidation or reorganization, such surviving or successor entity is not the Company); or
(iii) any sale or other transfer by the stockholders of the

    	2

    	

    

Company of shares representing at least
a majority of the Company’s then-total outstanding combined voting power; provided, that neither of the following shall be considered
an Acquisition: (x) a merger or consolidation effected solely for purposes of changing the Company’s domicile, or (y) any transaction
or series of related transactions the principal purpose of which is a bona fide equity financing of the Company.

 

(b) Treatment of
Warrant at Acquisition. In the event of an Acquisition in which the consideration to be received by the Company’s stockholders
consists solely of cash, solely of Marketable Securities or a combination of cash and Marketable Securities (a “Cash/Public
Acquisition”), either (i) Holder shall exercise this Warrant pursuant to Section 1.1 and/or 1.2 and such exercise
will be deemed effective immediately prior to and contingent upon the consummation of such Acquisition or (ii) if Holder elects
not to exercise the Warrant, this Warrant will expire immediately prior to the consummation of such Acquisition.

 

(c) The Company shall
provide Holder with written notice of its request relating to the Cash/Public Acquisition (together with such reasonable information
as Holder may reasonably require regarding the treatment of this Warrant in connection with such contemplated Cash/Public Acquisition
giving rise to such notice), which is to be delivered to Holder not less than seven (7) Business Days prior to the closing of the
proposed Cash/Public Acquisition. In the event the Company does not provide such notice, then if, immediately prior to the Cash/Public
Acquisition, the fair market value of one Share (or other security issuable upon the exercise hereof) as determined in accordance
with Section 1.3 above would be greater than the Warrant Price in effect on such date, then this Warrant shall automatically be
deemed on and as of such date to be exercised pursuant to Section 1.2 above as to all Shares (or such other securities) for which
it shall not previously have been exercised, and the Company shall promptly notify the Holder of the number of Shares (or such
other securities) issued upon such exercise to the Holder and Holder shall be deemed to have restated each of the representations
and warranties in Section 4 of the Warrant as the date thereof.

 

(d) Upon the closing
of any Acquisition other than a Cash/Public Acquisition, the acquiring, surviving or successor entity shall assume the obligations
of this Warrant, and this Warrant shall thereafter be exercisable for the same securities and/or other property as would have been
paid for the Shares issuable upon exercise of the unexercised portion of this Warrant as if such Shares were outstanding on and
as of the closing of such Acquisition, subject to further adjustment from time to time in accordance with the provisions of this
Warrant.

 

(e) As used in this
Warrant, “Marketable Securities” means securities meeting all of the following requirements: (i) the issuer
thereof is then subject to the reporting requirements of Section 13 or Section 15(d) of the Securities Exchange Act of 1934, as
amended (the “Exchange Act”), and is then current in its filing of all required reports and other information
under the Act and the Exchange Act; (ii) the class and series of shares or other security of the issuer that would be received
by Holder in connection with the Acquisition were Holder to exercise this Warrant on or prior to the closing thereof is then traded
in Trading Market, and (iii) following the closing of such Acquisition, Holder would not be restricted from publicly re-selling
all of the issuer’s shares and/or other securities that would be received by Holder in such Acquisition were Holder to exercise
or convert this Warrant in full on or prior to the closing of such Acquisition, except to the extent that any such restriction
(x) arises solely under federal or state securities laws, rules or regulations, and (y) does not extend beyond six (6) months from
the closing of such Acquisition.

    	3

    	

    

1.7 Stockholders’
Agreement. Upon any exercise of this Warrant, Holder agrees that it shall be subject to and bound by (and shall, if the Company
so requests in writing, become a party to, by execution and delivery to the Company of a counterpart signature page, joinder agreement,
instrument of accession or similar instrument), the Company’s Sixth Amended and Restated Stockholder Rights Agreement dated
November 10, 2012, as amended and/or restated and in effect from time to time (the “Stockholders’ Agreement”),
solely with respect to the Shares issued upon such exercise, solely to the extent that all holders of one percent (1%) or more
of the outstanding shares of the Class (determined on an as-converted-to-common-stock basis) are then parties thereto, and solely
to the extent that the Stockholders’ Agreement is then by its terms in force and effect.

 

SECTION 2. ADJUSTMENTS TO THE SHARES
AND WARRANT PRICE.

 

2.1 Stock Dividends,
Splits, Etc. If the Company declares or pays a dividend or distribution on the outstanding shares of the Class payable in additional
shares of the Class or other securities or property (other than cash), then upon exercise of this Warrant, for each Share acquired,
Holder shall receive, without additional cost to Holder, the total number and kind of securities and property which Holder would
have received had Holder owned the Shares of record as of the date the dividend or distribution occurred. If the Company subdivides
the outstanding shares of the Class by reclassification or otherwise into a greater number of shares, the number of Shares purchasable
hereunder shall be proportionately increased and the Warrant Price shall be proportionately decreased. If the outstanding shares
of the Class are combined or consolidated, by reclassification or otherwise, into a lesser number of shares, the Warrant Price
shall be proportionately increased and the number of Shares shall be proportionately decreased.

 

2.2 Reclassification,
Exchange, Combinations or Substitution. Upon any event whereby all of the outstanding shares of the Class are reclassified,
exchanged, combined, substituted, or replaced for, into, with or by Company securities of a different class and/or series, then
from and after the consummation of such event, this Warrant will be exercisable for the number, class and series of Company securities
that Holder would have received had the Shares been outstanding on and as of the consummation of such event, and subject to further
adjustment thereafter from time to time in accordance with the provisions of this Warrant. The provisions of this Section 2.2 shall
similarly apply to successive reclassifications, exchanges, combinations substitutions, replacements or other similar events.

 

2.3 No Fractional
Share. No fractional Share shall be issuable upon exercise of this Warrant and the number of Shares to be issued shall be rounded
down to the nearest whole Share. If a fractional Share interest arises upon any exercise of the Warrant, the Company shall eliminate
such fractional Share interest by paying Holder in cash the amount computed by multiplying the fractional interest by (i) the fair
market value (as determined in accordance with Section 1.3 above) of a full Share, less (ii) the then-effective Warrant Price.

 

2.4 Notice/Certificate
as to Adjustments. Upon each adjustment of the Warrant Price, Class and/or number of Shares, the Company, at the Company’s
expense, shall notify Holder in writing within a reasonable time setting forth the adjustments to the Warrant Price, Class and/or
number of Shares and facts upon which such adjustment is based. The Company shall, upon written request from Holder, furnish Holder
with a certificate of its Chief Financial Officer, including computations of such adjustment and the Warrant Price, Class and
number of Shares in effect upon the date of such adjustment.

    	4

    	

    

2.5 Pay to Play Adjustments.
Notwithstanding the definition of Class herein, if Pay to Play Provisions are at any time during the term of this Warrant applied
to the outstanding shares of the Class, then from and after such application, “Class” shall mean that class and series
of the Company’s securities that a holder of outstanding shares of the Class as of immediately prior to such application would
have received or retained had such holder participated in the manner necessary to receive or retain the class and series of the
Company’s securities having the relative rights, powers, privileges and preferences more favorable to the holder. As used herein,
“Pay to Play Provisions” means provisions set forth in the Company’s Certificate of Incorporation or elsewhere that require
holders of the outstanding shares of the Class to participate in a subsequent round of equity financing of the Company or lose
all or a portion of the benefit of anti-dilution protection or any other right, power, privilege or preference applicable to such
shares or have such shares automatically convert to another class or series of Company capital stock.

 

SECTION 3. REPRESENTATIONS AND COVENANTS
OF THE COMPANY.

 

3.1 Representations
and Warranties. The Company represents and warrants to, and agrees with, the Holder as follows:

 

(a) The number of Shares
for which this Warrant is exercisable on and as of the Issue Date hereof represents not less than 0.414% of the Company’s total
issued and outstanding shares of common stock, calculated on a fully-diluted basis assuming the conversion into common stock of
all outstanding securities and instruments convertible by their terms into shares of common stock (regardless of whether such securities
or instruments are by their terms now so convertible) and the exercise in full of all outstanding options, warrants (including,
without limitation, this Warrant) and other rights to purchase or acquire shares of common stock or securities exercisable for
or convertible into shares of common stock (regardless of whether such options, warrants or other rights to purchase or acquire
are by their terms now exercisable).

 

(b) All Shares which
may be issued upon the exercise of this Warrant shall, upon issuance, be duly authorized, validly issued, fully paid and non-assessable,
and free of any liens and encumbrances except for restrictions on transfer provided for herein, under the Stockholders’ Agreement
(to the extent Holder is then a party thereto or is by the terms of Section 1.7 above subject thereto and bound thereby) or under
applicable federal and state securities laws. The Company covenants that it shall at all times cause to be reserved and kept available
out of its authorized and unissued capital stock such number of shares of the Class and other securities as will be sufficient
to permit the exercise in full of this Warrant.

 

(c) The Company’s capitalization
table attached hereto as Schedule 1 is true and complete, in all material respects, as of the Issue Date.

 

3.2 Notice of Certain
Events. If the Company proposes at any time to:

 

(a) declare any dividend
or distribution upon the outstanding shares of the Class, whether in cash, property, stock, or other securities and whether or
not a regular cash dividend;

 

(b) offer for subscription
or sale pro rata to the holders of the outstanding shares of the Class any additional shares of any class or series of the Company’s
stock (other than pursuant to contractual pre-emptive rights);

    	5

    	

    

(c) effect any reclassification,
exchange, combination, substitution, reorganization or recapitalization of the outstanding shares of the Class;

 

(d) effect an Acquisition
or to liquidate, dissolve or wind up; or

 

(e) effect its initial,
underwritten offering and sale of its securities to the public pursuant to an effective registration statement under the Act (the
“IPO”);

 

then, in connection with each such event,
the Company shall give Holder:

 

(1) in the
case of the matters referred to in (a) and (b) above, at least seven (7) Business Days prior written notice of the earlier to occur
of the effective date thereof or the date on which a record will be taken for such dividend, distribution, or subscription rights
(and specifying the date on which the holders of outstanding shares of the Class will be entitled thereto) or for determining rights
to vote, if any;

 

(2) in the
case of the matters referred to in (c) and (d) above at least seven (7) Business Days prior written notice of the date when the
same will take place (and specifying the date on which the holders of outstanding shares of the Class will be entitled to exchange
their shares for the securities or other property deliverable upon the occurrence of such event); and

 

(3)-with respect
to the IPO, at least seven (7) Business Days prior written notice of the date on which the Company proposes to file its registration
statement in connection therewith.

 

Reference is made to Section 1.6(c) whereby
this Warrant will be deemed to be exercised pursuant to Section 1.2 hereof if the Company does not give written notice to Holder
of a Cash/Public Acquisition as required by the terms hereof. Company will also provide information requested by Holder that is
reasonably necessary to enable Holder to comply with Holder’s accounting or reporting requirements.

 

SECTION 4. REPRESENTATIONS, WARRANTIES
OF THE HOLDER.

 

The Holder represents and warrants to the
Company as follows:

 

4.1 Purchase for
Own Account. This Warrant and the Shares to be acquired upon exercise of this Warrant by Holder are being acquired for investment
for Holder’s account, not as a nominee or agent, and not with a view to the public resale or distribution within the meaning of
the Act. Holder also represents that it has not been formed for the specific purpose of acquiring this Warrant or the Shares.

 

4.2 Disclosure of
Information. Holder is aware of the Company’s business affairs and financial condition and has received or has had full access
to all the information it considers necessary or appropriate to make an informed investment decision with respect to the acquisition
of this Warrant and its underlying securities. Holder further has had an opportunity to ask questions and receive answers from
the Company regarding the terms and conditions of the offering of this Warrant and its underlying securities and to obtain additional
information (to the extent the Company possessed such information or could acquire it without unreasonable effort or expense)
necessary to verify any information furnished to Holder or to which Holder has access.

    	6

    	

    

4.3 Investment Experience.
Holder understands that the purchase of this Warrant and its underlying securities involves substantial risk. Holder has experience
as an investor in securities of companies in the development stage and acknowledges that Holder can bear the economic risk of such
Holder’s investment in this Warrant and its underlying securities and has such knowledge and experience in financial or business
matters that Holder is capable of evaluating the merits and risks of its investment in this Warrant and its underlying securities
and/or has a preexisting personal or business relationship with the Company and certain of its officers, directors or controlling
persons of a nature and duration that enables Holder to be aware of the character, business acumen and financial circumstances
of such persons.

 

4.4 Accredited Investor
Status. Holder is an “accredited investor” within the meaning of Regulation D promulgated under the Act.

 

4.5 The Act.
Holder understands that this Warrant and the Shares issuable upon exercise hereof have not been registered under the Act in reliance
upon a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of the Holder’s investment
intent as expressed herein. Holder understands that this Warrant and the Shares issued upon any exercise hereof must be held indefinitely
unless subsequently registered under the Act and qualified under applicable state securities laws, or unless exemption from such
registration and qualification are otherwise available. Holder is aware of the provisions of Rule 144 promulgated under the Act.

 

4.6 No Voting Rights.
Holder, as a Holder of this Warrant, will not have any voting rights until the exercise of this Warrant.

 

4.7 Market Stand-off
Agreement. The Holder agrees that the Shares shall be subject to the Market Standoff provisions in Section 2.12 of the Stockholders’
Agreement.

 

SECTION 5. MISCELLANEOUS.

 

5.1 Term; Automatic
Cashless Exercise Upon Expiration.

 

(a) Term. Subject
to the provisions of Section 1.6 above, this Warrant is exercisable in whole or in part at any time and from time to time on or
before 6:00 PM, Pacific time, on the Expiration Date and shall be void thereafter.

 

(b) Automatic Cashless
Exercise upon Expiration. In the event that, upon the Expiration Date, the fair market value of one Share as determined in
accordance with Section 1.3 above is greater than the Warrant Price in effect on such date, then this Warrant shall automatically
be deemed on and as of such date to be exercised pursuant to Section 1.2 above as to all Shares for which it shall not previously
have been exercised, and the Company shall, within a reasonable time, deliver a certificate representing the Shares issued upon
such exercise to Holder.

 

5.2 Legends.
Each certificate evidencing Shares shall be imprinted with a legend in substantially the following form:

 

THE SHARES EVIDENCED BY THIS
CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE
SECURITIES LAWS OF ANY STATE AND, EXCEPT

    	7

    	

    

AS SET FORTH IN THAT
CERTAIN WARRANT TO PURCHASE STOCK ISSUED BY THE ISSUER TO WESTRIVER MEZZANINE LOANS, LLC DATED OCTOBER 22, 2012, MAY NOT BE
OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF
LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM
SUCH REGISTRATION.

 

5.3 Compliance with
Securities Laws on Transfer. This Warrant and the Shares issued upon exercise of this Warrant may not be transferred or assigned
in whole or in part except in compliance with applicable federal and state securities laws by the transferor and the transferee
(including, without limitation, the delivery of investment representation letters and legal opinions reasonably satisfactory to
the Company, as reasonably requested by the Company). The Company shall not require Holder to provide an opinion of counsel if
the transfer is to an affiliate of Holder, provided that such affiliate is an “accredited investor” as defined in Regulation
D promulgated under the Act. Additionally, the Company shall also not require an opinion of counsel if there is no material question
as to the availability of Rule 144 promulgated under the Act.

 

5.4 Transfer Procedure.
Subject to the provisions of Section 5.3 and upon providing the Company with written notice, Holder may transfer all or part of
this Warrant or the Shares issued upon exercise of this Warrant (or the securities issued upon conversion of the Shares, if any)
to any transferee, provided, however, in connection with any such transfer, Holder will give the Company notice of the portion
of the Warrant and/or Shares (and/or securities issued upon conversion of the Shares, if any) being transferred with the name,
address and taxpayer identification number of the transferee and Holder will surrender this Warrant to the Company for reissuance
to the transferee(s) (and Holder if applicable); and provided further, that any subsequent transferee shall agree in writing with
the Company to be bound by all of the terms and conditions of this Warrant. Notwithstanding any contrary provision herein, at all
times prior to the IPO, Holder may not, without the Company’s prior written consent, transfer this Warrant or any portion hereof,
or any Shares issued upon any exercise hereof, or any shares or other securities issued upon any conversion of any Shares issued
upon any exercise hereof, to any person or entity who directly competes with the Company, except in connection with an Acquisition
of the Company by such a direct competitor.

 

5.5 Notices.
All notices and other communications hereunder from the Company to the Holder, or vice versa, shall be deemed delivered and effective
(i) when given personally, (ii) on the third (3rd) Business Day after being mailed by first-class registered or certified
mail, postage prepaid, (iii) upon actual receipt if given by facsimile or electronic mail and such receipt is confirmed in writing
by the recipient, or (iv) on the first Business Day following delivery to a reliable overnight courier service, courier fee prepaid,
in any case at such address as may have been furnished to the Company or Holder, as the case may be, in writing by the Company
or such Holder from time to time in accordance with the provisions of this Section 5.5. All notices to Holder shall be addressed
as follows until the Company receives notice of a change of address in connection with a transfer or otherwise:

 

WestRiver Mezzanine Loans, LLC

c/o WestRiver Management, LLC

3720 Carillon Point

Kirkland, Washington 98033-7455

Attention: Erik J. Anderson

    	8

    	

    

Telephone: (425) 576-9850

Email: eanderson@westrivercap.com

With a copy (which shall not constitute notice) to:

Perkins Coie LLP

1201 Third Avenue, Suite 4800

Seattle, Washington 98101-3099

Attention: David C. Clarke

Telephone: (206) 359-8612

Email: dclarke@perkinscoie.com

 

Notice to the Company shall be addressed
as follows until Holder receives notice of a change in address:

 

Everyday Health, Inc.

Attn: Alan Shapiro

345 Hudson Street, 16th Floor

New York, NY 10014

Facsimile: (646) 728-9506

Email: ashapiro@everydayhealthinc.com

With a copy (which shall not constitute notice) to:

Cooley LLP

Attn: Babak (Bo) Yaghmaie, Esq.

1114 Avenue of the Americas

New York, NY 10036

Facsimile: (212) 479-6275

Email: bo@cooley.com

 

5.6 Waiver. This
Warrant and any term hereof may be changed, waived, discharged or terminated (either generally or in a particular instance and
either retroactively or prospectively) only by an instrument in writing signed by the party against which enforcement of such change,
waiver, discharge or termination is sought.

 

5.7 Attorneys’ Fees.
In the event of any dispute between the parties concerning the terms and provisions of this Warrant, the party prevailing in such
dispute shall be entitled to collect from the other party all costs incurred in such dispute, including reasonable attorneys’ fees.

 

5.8 Counterparts;
Facsimile/Electronic Signatures. This Warrant may be executed in counterparts, all of which together shall constitute one
and the same agreement. Any signature page delivered electronically or by facsimile shall be binding to the same extent as an
original signature page with regards to any agreement subject to the terms hereof or any amendment thereto.

    	9

    	

    

5.9 Governing Law.
This Warrant shall be governed by and construed in accordance with the laws of the State of New York, without giving effect to
its principles regarding conflicts of law.

 

5.10 Headings.
The headings in this Warrant are for purposes of reference only and shall not limit or otherwise affect the meaning of any provision
of this Warrant.

 

5.11 Business Days.
“Business Day” is any day that is not a Saturday, Sunday or a day on which WestRiver Mezzanine Loans,
LLC is closed.

 

[Remainder of page left blank intentionally]

[Signature page follows]

    	10

    	

    

IN WITNESS WHEREOF,
the parties have caused this Warrant to Purchase Stock to be executed by their duly authorized representatives effective as of
the Issue Date written above.

 

“COMPANY”

 

EVERYDAY HEALTH, INC.

 

	By: 	/s/ Alan Shapiro	 

 

	Name: 	Alan Shapiro	 
	 	(Print)	 
	Title: 	EVP and General Counsel	 

 

“HOLDER”

 

WESTRIVER MEZZANINE LOANS, LLC

 

	By: 	WestRiver Management, LLC, its
	 	Managing Member

 

	By: 	/s/ Erik J. Anderson, Manager	 
	 	Erik J. Anderson, Manager	 

    	11

    	

    

APPENDIX 1

 

NOTICE OF EXERCISE

 

1. The undersigned Holder
hereby exercises its right to purchase ____________ shares of the Common/Series _______ Preferred [circle one] Stock of ____________________
(the “Company”) in accordance with the attached Warrant To Purchase Stock, and tenders payment of the aggregate
Warrant Price for such shares as follows:

 

	 	£	check in the amount of $ ________ payable
    to order of the Company enclosed herewith
	 	 	 
	 	£	Wire transfer of immediately available funds to the Company’s account
	 	 	 
	 	£	Cashless Exercise pursuant to Section 1.2 of the Warrant

	 	 	 
	 	£	Other [Describe] 	 	 

 

2. Please issue a certificate
or certificates representing the Shares in the name specified below:

 

 

	 	 	 
	 	Holder’s Name	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	(Address)	 

 

3. By its execution
below and for the benefit of the Company, Holder hereby restates each of the representations and warranties in Section 4 of the
Warrant to Purchase Stock as of the date hereof.

 

	 	HOLDER:	 
	 	 	 
	 	 	 
	 	 	 	 
	 	By: 	 	 
	 	 	 	 

	 	Name: 	 	 
	 	 	 	 
	 	Title:	 	 
	 	 	 	 
	 	(Date): 	 	 

 

Appendix 1

    	 

    	

    

SCHEDULE 1

Company Capitalization Table

See attached

 

Schedule 1exv10w1

Exhibit 10.1

AGORA MEDIA INC.

2003 STOCK OPTION PLAN, AS AMENDED

     1. Purpose. Agora Media Inc., a Delaware corporation (“Agora”), desires to attract
and retain the best available talent and to encourage the highest level of performance. The Agora
Media Inc. 2003 Stock Option Plan, as amended (the “Plan”), is intended to contribute
significantly to the attainment of these objectives by affording eligible employees and independent
contractors of Agora and its affiliates (whether or not incorporated) (collectively, with Agora,
the “Company”) the opportunity to acquire a proprietary interest in Agora through the grant
of stock options (“Options”) to purchase shares of common stock, $.01 par value per share,
of Agora (the “Common Stock”).

     2. Administration.

          (a) In General. Subject to paragraph (b) hereof, the Plan shall be administered by
the board of directors of Agora (the “Board”). The Board shall have plenary authority in
its discretion, to the maximum extent permissible by law, subject to and not inconsistent with the
express provisions of the Plan, to make all awards of Options under the Plan, to select from among
eligible persons those individuals who will be awarded Options, to determine the number of shares
of Common Stock covered by each Option, the Option exercise price per share of Common Stock covered
by each Option (and, in connection therewith, determine the Fair Market Value of the Common Stock
for purposes of the Plan), and the restrictions, if any, which shall apply to the Common Stock
subject to an Option, to determine the terms and conditions of each Option, to approve the form of
each Option agreement (an “Option Agreement”), to amend any such Option Agreement from time
to time, to construe and interpret the Plan and all Option Agreements executed thereunder and to
make all other determinations necessary or advisable for the administration of the Plan. In
exercising its authority to set the terms and conditions of Options, and subject only to the limits
of applicable law, the Board shall be under no obligation or duty to treat similarly situated
grantees of an Option Agreement (“Optionees”) in the same manner, and any action taken by
the Board with respect to the grant of an Option to one Optionee shall in no way obligate the Board
to take the same or similar action with respect to any other Optionee. The Board may exercise its
discretion in a manner such that Options which are granted to individuals who are foreign nationals
or who are employed or provide services outside the United States, contain terms and conditions
which are different from the provisions otherwise specified in the Plan but which are consistent
with the tax and other laws of foreign jurisdictions applicable to the Optionee and which are
designed to provide the Optionee with benefits which are consistent with the Company’s objectives
in establishing the Plan. The Board may adopt such rules as it deems necessary or advisable in
order to carry out the purpose of the Plan. All questions of interpretation, administration and
application of the Plan shall be determined by a majority of the members of the Board then in
office, except that the Board may authorize any one or more of its members, or any officer of the
Company, to execute and deliver documents

 

 

(including any applicable Option Agreement) on behalf of the Board or Agora. Any
interpretation or determination made by the Board pursuant to the foregoing shall be conclusive and
binding upon any person having or claiming any interest under the Plan.

          (b) Appointment of Committee. Notwithstanding paragraph (a), the Board may appoint a
committee of not fewer than two members of the Board (the “Committee”) and transfer to the
Committee some or all of its authority hereunder. If the Board creates a Committee, the Board may
from time to time appoint members of the Committee in substitution for or in addition to members
previously appointed and may fill vacancies, however caused, in the Committee. If and when the
Common Stock is registered under Section 12 of the Securities Exchange Act of 1934, as amended (the
“Act”), to the extent necessary to comply with Rule
16b-3 under the Act with respect to Option grants to officers and directors, each member of
the Committee shall be a “non-employee director” within the meaning of Rule 16b-3 and, to the
extent necessary to exclude Options granted under the Plan from the calculation of the income tax
deduction limit under Section 162(m) of the Internal Revenue Code of 1986, as amended (the
“Code”), each member of the Committee shall be an “outside director” within the meaning of
Code Section 162(m). To the extent necessary to be consistent with the provisions of this
paragraph (b), any reference in the Plan and/or an Option Agreement to a decision, determination or
action of the Board shall be read and understood as referring to a decision, determination or
action of the Committee.

          (c) Liability of Board and Committee Members. Except as otherwise required by law, no
member of the Board or the Committee shall be liable for anything whatsoever in connection with the
administration of the Plan other than such member’s own willful misconduct. Under no circumstances
shall any member of the Board or the Committee be liable for any act or omission of any other
member of the Board or the Committee. In the performance of its functions with respect to the
Plan, the Board and the Committee shall be entitled to rely upon information and advice furnished
by Agora’s officers, Agora’s accountants, Agora’s legal counsel and any other party the Board and
Committee deems necessary, and no member of the Board or Committee shall be liable for any action
taken or not taken in reliance upon any such advice.

     3. Type of Options. Options granted under the Plan may be either incentive stock
options (“ISOs”) intended to meet the requirements of Code Section 422 or nonqualified
stock options (“NSOs”) which are not intended to meet such Code requirements.

     4. Eligible Persons. Subject in the case of ISOs to Section 17(a), Options may be
awarded only to officers, employees and independent contractors of the Company. For purposes
hereof, the term “independent contractors” shall include consultants, advisors and directors of the
Company. In determining the persons to whom awards shall be made and the number of shares to be
covered by each Option, the Board shall take into account the duties of the respective persons,
their present and potential contributions to the success of the Company and such other factors as
the Board, in its discretion, shall deem relevant in connection with accomplishing the purposes of
the Plan.

     5. Shares
    Subject to the Plan. No more than Nine Million Eight Hundred Fifty Thousand
(9,850,000) shares of Common Stock shall be issued pursuant to the exercise
    of Options granted under the Plan. Such aggregate number shall be subject
    to adjustment as provided in Section 16.
If an Option is forfeited or expires without being exercised, the shares of Common
    Stock subject

2

 

to the Option shall be available for additional Option grants under the Plan. If an Option is
exercised in whole or in part by an Optionee by tendering previously owned shares of Common Stock,
or if any shares are withheld in connection with the exercise of its Option to satisfy the
Optionee’s tax liability, the full number of shares in respect of which the Option has been
exercised shall be applied against the limit set forth in this Section 5.

     6. Term of Options. The term of each Option shall be fixed by the Board and specified
in the applicable Option Agreement, but in no event shall it be more than ten years from the date
of grant, subject to earlier termination as provided in Section 8. Subject in the case of ISOs to
Section 17, the term of an Option may be extended from time to time by the Board, provided that no
such extension shall extend the term beyond ten years from the date of grant.

     7. Vesting. The Board shall determine the vesting schedule applicable to a particular
Option grant and specify the vesting schedule in the applicable Option Agreement. Notwithstanding
the foregoing the Board may accelerate the vesting of an Option at any time.

     8. Termination of Relationship to the Company.

          (a) Options Granted To Employees. With respect to an Option granted to an individual
who is an employee of the Company at the time of Option grant, unless the Option Agreement
expressly provides to the contrary, (i) the Option shall terminate immediately upon the Optionee’s
termination of employment for Cause (as defined in Section 23); (ii) in the event that the
Optionee’s employment with the Company shall terminate by reason of death or Disability (as
hereinafter defined), the unvested portion of the Option shall terminate immediately and the vested
portion of the Option shall terminate one year following such termination of employment (but shall
not continue to vest during such one year period); and (iii) in the event that the Optionee’s
employment with the Company shall terminate for any other reason, the unvested portion of the
Option shall terminate immediately and the vested portion of the Option shall terminate three
months after such termination of employment (but shall not continue to vest during such three month
period); provided, however, that in the event that the Optionee is subject to any non-compete or
confidentiality agreement which he or she violates, the Option shall immediately terminate upon
such violation. Notwithstanding anything herein to the contrary, in no event shall an Option
remain exercisable beyond the expiration date specified in the applicable Option Agreement. An
Option Agreement may contain such provisions as the Board shall approve with reference to the
determination of the date employment terminates for purposes of the Plan and the effect of leaves
of absence, which provisions may vary from one Option Agreement to another. For purposes hereof,
the Optionee shall be deemed to have a “Disability” if the Optionee is permanently and totally
disabled, within the meaning of Section 22(e) of the Code.

          (b) Options Granted to Independent Contractors. With respect to an Option granted to
an individual who is not an employee of the Company at the time of Option grant, the Board shall
determine and specify in the applicable Option Agreement the consequences, if any, of the
termination of the Optionee’s relationship with the Company.

     9. Option Exercise Price. Subject in the case of ISOs to Section 17, the Option
exercise price per share of Common Stock covered by an Option shall be established by the Board.

     10. Exercise of Options.

3

 

          (a) An Option may be exercised at any time and from time to time, in whole or in part, as to
any or all full shares as to which the Option is then exercisable; provided, however, that if so
specified in the Option Agreement, the Option may not, in a single exercise, be exercised for fewer
than the minimum number of shares specified in the Option Agreement, unless the exercise is for all
of the shares as to which the Option is then exercisable. An Option may not be exercised with
respect to a fractional share. If an Option is exercised with respect to all of the whole shares
as to which the Option is exercisable, and the Option remains exercisable with respect to less than
one share of Common Stock, the Option shall immediately and without any further action by the
Company or the Optionee be cancelled with respect to the remaining fractional share, without any
consideration being paid by the Company. An Optionee (or other person who, pursuant to Section 13,
may exercise the Option) shall exercise the Option by delivering to Agora at the address provided
in the Option Agreement a written, signed notice of exercise, stating the number of shares of
Common Stock with respect to which the option exercise is being made, and satisfy the requirements
of paragraph (b) of this Section 10. Upon receipt by Agora of any notice of exercise, the exercise
of the Option as set forth in that notice shall be irrevocable.

          (b) Upon exercise of an Option the Optionee shall pay to Agora the Option exercise price per
share of Common Stock multiplied by the number of full shares as to which the Option is then
exercised. An Optionee may pay the Option exercise price by tendering or causing to be tendered in
cash, by delivery of shares of Common Stock owned by the Optionee for at least six months preceding
the date of exercise of the Option (or such shorter or longer period as the Board may approve or
require from time to time) having a Fair Market Value equal to the exercise price or other property
permitted by law and acceptable to the Board, or any combination thereof. Without limiting the
foregoing, after the Common Stock becomes Publicly Traded (as defined in Section 23), payment of
the exercise price may be facilitated by an outside broker.

          (c) An Optionee shall, upon notification of the amount due and prior to or concurrently with
delivery of the certificate representing the shares as to which the Option has been exercised,
promptly pay or cause to be paid the amount determined by the Board as necessary to satisfy all
applicable tax and other withholding requirements. An Optionee may satisfy his withholding
requirement in any manner satisfactory to the Board.

          (d) If at the time of Option exercise (i) the Common Stock is not Publicly Traded and (ii) the
Optionee is so requested by Agora, prior to or concurrently with delivery of the certificate
representing the shares as to which the Option has been exercised, the Optionee shall become a
party to a stockholders agreement between stockholders of Agora and Agora.

          (e) The certificate representing the shares as to which an Option has been exercised shall
bear an appropriate legend setting forth the restrictions applicable to such shares.

     11. Option Agreement. The terms and conditions of each Option shall be set forth in
an Option Agreement in the form approved by the Board. Each Option Agreement shall be executed by
Agora and the Optionee. Each Option Agreement shall, at a minimum, specify (i) the number of
shares of Common Stock subject to the Option, (ii) whether the Option is intended to be an ISO or
NSO, (iii) the provisions related to vesting and exercisability of the Option, including the Option
exercise price, and (iv) that the Option is subject to the terms and provisions of the Plan and
that in the event of any conflict between the Option Agreement and

4

 

the Plan, the Plan shall control. The Option Agreement may also contain such other terms and
conditions as the Board determines to be necessary or advisable. Option Agreements may vary from
one to another.

     12. No Stockholder Rights. No Optionee shall have the rights of a stockholder with
respect to shares covered by an Option until such person becomes the holder of record of such
shares. If in connection with an exercise of the Option the Optionee pays all or a portion of the
Option exercise price with shares of Common Stock, the Optionee shall continue to be the
stockholder of record with respect to the shares which he has tendered as exercise payment until
the Optionee becomes the holder of record of the shares of Common Stock to be acquired upon such
exercise.

     13. Nontransferability.

          (a) Subject to paragraphs (b) and (c), Options granted under the Plan shall not be assignable
or transferable other than by will or the laws of descent and distribution and Options may be
exercised during the lifetime of the Optionee only by the Optionee or by the Optionee’s guardian or
legal representative. In the event of any attempt by an Optionee to transfer, assign, pledge,
hypothecate or otherwise dispose of an Option or any right thereunder, except as provided for
herein, or in the event of the levy of any attachment, execution or similar process upon the rights
or interest hereby conferred, Agora may terminate the Option by notice to the Optionee and it shall
thereupon become null and void.

          (b) Notwithstanding paragraph (a), if and only if (and on the terms) so provided in the
applicable Option Agreement, an Optionee may transfer a NSO, by gift or a domestic relations order,
to a Family Member of the Optionee (as defined in Section 23). If a NSO is transferred in
accordance with this subparagraph, the Option shall be exercisable solely by the transferee, but
the determination of the exercisability of the Option shall be based solely on the activities and
state of affairs of the Optionee. Thus, for example, if after a transfer the Optionee ceases to be
an employee of the Company, such termination shall trigger the provisions of Section 8 hereof.
Conversely, if after a transfer the transferee ceases to be an employee of the Company, such
termination shall not trigger the provisions of Section 8 hereof.

          (c) Notwithstanding paragraph (a) an Optionee may transfer an NSO with the express, written
consent of the Board (which consent may be withheld for any reason or for no reason).

     14. Compliance with Law; Registration of Shares.

          (a) The Plan and any grant hereunder shall be subject to all applicable laws, rules, and
regulations of any applicable jurisdiction or authority or agency thereof and to such approvals by
any regulatory or governmental authority or agency or securities exchange which, in the opinion of
Company’s counsel, may be required or appropriate.

          (b) Notwithstanding any other provision of the Plan or Option Agreements made pursuant hereto,
the Company shall not be required to issue or deliver any certificate or certificates for shares of
Common Stock under the Plan prior to fulfillment of all of the following conditions:

               i. Effectiveness of any registration or other qualification of such shares of the Company
under any law or regulation of any applicable jurisdiction or authority or agency

5

 

thereof which the Board shall, in its absolute discretion or upon the advice of counsel, deem
necessary or advisable; and

               ii. Grant of any other consent, approval or permit from any applicable jurisdiction or
authority or agency thereof or securities exchange which the Board shall, in its absolute
discretion or upon the advice of counsel, deem necessary or advisable.

     The Company shall use all reasonable efforts to obtain any consent, approval or permit
described above; provided, however, that except to the extent as may be specifically required in an
Option Agreement with respect to any particular Option grant, the Company shall be under no
obligation to register or qualify any shares subject to an Option under any federal or state
securities law or on any exchange.

     15. No Restriction on the Right of Agora to Effect Corporate Changes. The Plan and
the Options granted hereunder shall not affect in any way the right or power of Agora or its
stockholders to make or authorize any or all adjustments, recapitalization, reorganizations or
other changes in Agora’s or the Company’s capital structure or its business, or any merger or
consolidation of Agora or the Company, or any issue of stock or of options, warrants or rights to
purchase stock or of bonds, debentures, preferred or prior preference stocks whose rights are
superior to or affect the Common Stock or the rights of holders thereof or which are convertible
into or exchangeable for Common Stock, or the dissolution or liquidation of Agora or the Company,
or any sale or transfer of all or any part of its assets or business, or any other corporate act or
proceeding, whether of a similar character or otherwise.

     16. Certain Adjustments.

          (a) In the event that Agora or the division, subsidiary or other affiliated entity for which
an Optionee performs services is sold (including a stock or an asset sale), spun off, merged,
consolidated, reorganized or liquidated, the Board may determine that (i) the Option shall be
assumed, or a substantially equivalent Option shall be substituted, by an acquiring or succeeding
entity (or an affiliate thereof) on such terms as the Board determines to be appropriate; (ii)
upon written notice to the Optionee, provide that the Option shall terminate immediately prior to
the consummation of the transaction unless exercised by the Optionee within a specified period
following the date of the notice; (iii) in the event of a sale or similar transaction under the
terms of which holders of Common Stock receive a payment for each share of Common Stock surrendered
in the transaction (the “Sales Price”), make or provide for a payment to each Optionee
equal to the amount by which (A) the Sales Price times the number of shares of Common Stock subject
to the Option (to the extent such Option is then exercisable) exceeds (B) the aggregate exercise
price for all such shares of Common Stock; or (iv) may make such other equitable adjustments as
the Board deems appropriate. Notwithstanding the foregoing, if so specified in an Optionee’s
Option Agreement, if the event described in this paragraph is one in which holders of Common Stock
are to receive stock in the acquiror or an affiliate thereof that is not Publicly Traded, the
Optionee shall be given notice of the transaction and an opportunity prior to the consummation of
the transaction to exercise the Optionee’s vested Option, so that with respect to such vested
Option, the Optionee shall have an opportunity to receive the stock of the acquiror (or its
affiliate) on the same basis as the other holders of Common Stock.

6

 

          (b) In the event of any stock dividend or split, recapitalization, combination, exchange or
similar change affecting the Common Stock, or any other increase or decrease in the number of
issued shares of Common Stock effected without receipt of consideration by the Company, the Board
shall make any or all of the following adjustments as it deems appropriate to equitably reflect
such event: (i) adjust the aggregate number of shares (or such other security as is designated by
the Board) which may be acquired pursuant to the Plan, (ii) adjust the option price to be paid for
any or all such shares subject to the then outstanding Options, (iii) adjust the number of shares
of Common Stock (or such other security as is designated by the Board) subject to any or all of the
then outstanding Options and (iv) make any other equitable adjustments or take such other equitable
action as the Board, in its discretion, shall deem appropriate. For purposes hereof, the
conversion of any convertible securities of the Company shall not be deemed to have been “effected
without receipt of consideration.”

          (c) Any and all adjustments or actions taken by the Board pursuant to this Section shall be
conclusive and binding for all purposes.

     17. ISO Provisions.

          (a) Employment Requirement. ISOs may only be awarded to employees of Agora or a
corporation which, with respect to Agora, is a “parent corporation” or “subsidiary corporation”
within the meaning of Code Sections 424(e) and (f), respectively. Furthermore, except as otherwise
provided in Code Section 422, if an Optionee is no longer employed by Agora or a parent corporation
or subsidiary corporation of Agora, the Optionee’s Option shall cease to be treated as an ISO.

          (b) Option Exercise Price. Subject to paragraph (c), the Option exercise price per
share of Common Stock covered by an ISO shall be no less than the Fair Market Value of a share of
Common Stock on the date of grant of the Option.

          (c) 10% Stockholders. In the case of an individual who at the time the Option is
granted owns stock possessing more than 10% of the total combined voting power of all classes of
the stock of Agora or of a parent or subsidiary corporation of Agora, (i) the Option exercise price
of the Common Stock covered by any ISO granted to such person shall in no event be less than 110%
of the Fair Market Value of the Common Stock on the date the ISO is granted and (ii) the term of an
ISO granted to such person may not exceed five years from the date of grant.

          (d) $100,000 Limit. The aggregate Fair Market Value (determined at the time an ISO is
granted) of the Common Stock covered by ISOs exercisable for the first time by an employee during
any calendar year (under all plans of the Company) may not exceed $100,000.

          (e) Options Which Do Not Satisfy ISO Requirements. To the extent that any Option
which is issued under the Plan exceeds the limit set forth in paragraph (d) or otherwise does not
comply with the requirements of Code Section 422, it shall be treated as a NSO.

     18. No Right to Continued Employment. Neither the Plan nor any action taken hereunder
shall be construed as giving any employee or any independent contractor any right to continue in
the employ of or to be engaged as an independent contractor by the Company or affect the right of
the Company to terminate such person’s employment or other relationship with the Company at any
time.

7

 

     19. Amendment; Early Termination. The Board may at any time and from time to time
alter, amend, suspend or terminate the Plan in whole or in part; provided, however, that no
amendment requiring stockholder approval by law, rules or regulations, or by the rules of any stock
exchange, inter-dealer quotation system, or other market in which shares of Common Stock are
traded, shall be effective unless and until such stockholder approval has been obtained in
compliance with such rule or law; and provided, further, that no such amendment shall materially
adversely affect the rights of an Optionee in any Option previously granted under the Plan without
the Optionee’s written consent.

     20. Effective Date. The Plan shall be effective as of April 1, 2003 (the
“Effective Date”), subject to the approval thereof by the stockholders of Agora entitled to
vote thereon within 12 months of such date. In the event that such stockholder approval is not
obtained within such time period, the Plan and any Options granted under the Plan on or prior to
the expiration of such 12 month period shall be void and of no further force and effect.

     21. Termination of Plan. Unless terminated earlier by the Board in accordance with
Section 19 above, the Plan shall terminate on, and no further Options may be granted after, the
tenth anniversary of the Effective Date.

     22. Severability. In the event that any one or more provisions of the Plan or an
Option Agreement, or any action taken pursuant to the Plan or an Option Agreement, should, for any
reason, be unenforceable or invalid in any respect under the laws of the United States, any state
of the United States or any other jurisdiction, such unenforceability or invalidity shall not
affect any other provision of the Plan or Option Agreement, but in such particular jurisdiction and
instance the Plan and/or Option Agreement, as applicable, shall be construed as if such
unenforceable or invalid provision had not been contained therein or if the action in question had
not been taken thereunder.

     23. Definitions.

          (a) Cause. The term “Cause” when used herein in conjunction with termination of
employment (or other service relationship) means (i) if the Optionee is a party to an employment or
similar agreement with the Company which defines “cause” (or a similar term), the meaning set forth
in such agreement (other than death or Disability), or (ii) otherwise, termination by the Company
of the employment (or other service relationship) of the Optionee by reason of the Optionee’s (1)
intentional failure to perform reasonably assigned duties, (2) dishonesty or willful misconduct in
the performance of his duties, (3) involvement in a transaction which is materially adverse to the
Company, (4) breach of fiduciary duty involving personal profit, (5) willful violation of any law,
rule, regulation or court order (other than misdemeanor traffic violations and misdemeanors not
involving misuse or misappropriation of money or property), (6) commission of an act of fraud or
intentional misappropriation or conversion of any asset or opportunity of the Company, or (7)
material breach of any provision of the Plan, the Optionee’s Option Agreement or any other written
agreement between the Optionee and the Company, in each case as determined in good faith by the
Board, whose determination shall be final, conclusive and binding on all parties.

          (b) Fair Market Value. As used herein, the term “Fair Market Value” means, with
respect to Common Stock on any given date, the closing sales price of the Common Stock for such
date (or, in the event that the Common Stock is not traded on such date, on the immediately
preceding trading date) on the Nasdaq Stock Market or any stock exchange on

8

 

which the Common Stock may be listed, as reported in The Wall Street Journal. If the Common
Stock is not listed on the Nasdaq Stock Market or on a national stock exchange, but is quoted on
the OTC Bulletin Board or by the National Quotation Bureau, the Fair Market Value of the Common
Stock shall be the mean of the bid and asked prices per share of the Common Stock for such date.
If the Common Stock is not quoted or listed as set forth above, Fair Market Value shall be
determined by the Board in good faith by any fair and reasonable means (which means, with respect
to a particular Option grant, may be set forth with greater specificity in the applicable Option
agreement). The Fair Market Value of property other than Common Stock shall be determined by the
Board in good faith by any fair and reasonable means.

          (c) Family Member of the Optionee. As used herein, “Family Member of the Optionee”
means the Optionee’s lineal descendant, stepchild, parent, stepparent, grandparent, spouse, former
spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law,
brother-in-law, or sister-in-law, including adoptive relationships, any person sharing the
Optionee’s household (other than a tenant or employee), a trust in which the Optionee and/or these
persons have more than 50% of the beneficial interest, a foundation in which these persons (or the
Optionee) control the management of assets, and any other entity in which these persons (or the
Optionee) own more than 50% of the voting interests.

          (d) Publicly Traded. As used herein, Common Stock is “Publicly Traded” if stock of
that class is listed or admitted to unlisted trading privileges on a national securities exchange
or on the Nasdaq National Market or if sales or bid and offer quotations are reported for that
class of stock in the automated quotation system operated by the National Association of Securities
Dealers, Inc.

     24. Transfers to and from Affiliates. For all Plan purposes, a transfer of an
employee from Agora to an Agora affiliate or visa versa, or a transfer from one Agora affiliate to
another, will not be treated as a termination of employment.

     25. Headings. The headings of sections and subsections herein are included solely for
convenience of reference and shall not affect the meaning of any of the provisions of the Plan.

     26. Governing Law. This Plan and all rights hereunder shall be construed in
accordance with and governed by the laws of the State of New York, without regard to any conflict
of law provision that would defer to the substantive laws of another jurisdiction.

9

 

AGORA MEDIA INC.

2003 STOCK OPTION PLAN

NONQUALIFIED STOCK OPTION AGREEMENT

GENERAL PROVISIONS

     THIS AGREEMENT, made as of the Option Grant Date specified in the issuance sheet that is part
of this Nonqualified Stock Option Agreement that is attached hereto (the “Issuance Sheet”, and all
references to this Agreement shall include the Issuance Sheet), by and between Agora Media Inc., a
Delaware corporation (“Agora”), and the officer or employee of Agora or an Agora subsidiary or
affiliate (collectively, the “Company”) identified in the Issuance Sheet (the “Optionee”):

W I T N E S S E T H:

     WHEREAS, Agora has determined to grant stock options to attract and retain the best available
talent and to encourage the highest level of performance, all in accordance with the Agora Media
Inc. 2003 Stock Option Plan (the “Plan”);

     NOW, THEREFORE, in consideration of the foregoing and of the mutual covenants herein contained
and other good and valuable consideration, the parties hereto hereby agree as follows:

     1. Grant of Option. Subject to the terms and conditions of the Plan and this
Agreement, Agora hereby grants to the Optionee the right (the “Option”) to purchase all or any part
of an aggregate of the number of shares of common stock of Agora, par value $.001 per share
(“Common Stock”), specified in the Issuance Sheet.

     2. Vesting Schedule. The Option shall (i) vest (i.e., become exercisable) as to 25%
of all shares of Common Stock subject to the Option on the first anniversary of the Vesting
Commencement Date (as hereinafter defined); and (ii) vest as to the remaining 75% of all shares of
Common Stock subject to the Option on a monthly, pro rata, basis over a three year period
commencing on the first anniversary of the Vesting Commencement Date and ending on the fourth
anniversary of the Vesting Commencement Date, such that the Option shall be vested as to 100% of
all shares of Common Stock subject to the Option on the fourth anniversary of the Vesting
Commencement Date. By way of illustration, the Option shall be vested as to 37.5% of all shares of
Common Stock subject to the Option on the date one and one-half (11/2) years after the Vesting
Commencement Date. The “Vesting Commencement Date” shall be the Option Grant Date, unless a
different date is specified in the Issuance Sheet.

     3. Exercise Price. The price of each share of Common Stock purchased pursuant to this
Option shall be the exercise price specified in the Issuance Sheet.

     4. Manner of Exercise. The Optionee may exercise the Option, in whole or in part,
with respect to any whole number of shares of Common Stock subject to the Option that

 

 

are then vested. The Optionee shall exercise the Option by giving Agora written notice, in a
form prescribed by Agora. Such notice shall specify the number of shares of Common Stock to be
purchased and shall be accompanied by payment, in cash or certified check or by official bank
check, of an amount equal to the Option exercise price per share of Common Stock, multiplied by the
number of shares of Common Stock as to which the Option is being exercised; provided, however, that
the purchase price may be paid by (i) surrender or delivery to Agora of shares of Common Stock
owned by the Optionee for at least six months having a Fair Market Value on the date of exercise
equal to the portion of the purchase price being so paid, or (ii) after the Common Stock becomes
Publicly Traded (as defined in the Plan), by the delivery of funds equal to the purchase price by a
broker, in accordance with Regulation T promulgated by the Board of Governors of the Federal
Reserve System or as otherwise may be permissible by law. The Board may impose from time to time
such limitations as it deems appropriate on the use of shares of Common Stock to exercise the
Option.

     5. Delivery of Common Stock Certificate. Subject to Section 6, as soon as practicable
after receipt of the notice and payment referred to in Section 4 above, Agora shall deliver to the
Optionee (or, in the case of a broker financed exercise described in clause (ii) of Section 4, to
the broker) a certificate or certificates for such shares of Common Stock; provided, however, that
the time of such delivery may be postponed by Agora for such period of time as Agora may require
for compliance with any law, rule or regulation applicable to the issuance or transfer of shares of
Common Stock. The certificate or certificates representing the shares as to which the Option has
been exercised shall bear an appropriate legend setting forth any restrictions applicable to such
shares of Common Stock.

     6. Conditions to Common Stock Issuance. Prior to or concurrently with delivery by
Agora to the Optionee of a certificate(s) representing such shares of Common Stock, the Optionee
shall (i) upon notification of the amount due, promptly pay or cause to be paid, in cash, any
amount necessary to satisfy applicable tax requirements (or otherwise satisfy such withholding
requirements in a manner satisfactory to Agora), and (ii) if the shares of Common Stock are not
then registered under the Securities Act of 1933, as amended (the “Securities Act”) give assurance
satisfactory to Agora that such shares of Common Stock are being purchased for investment (unless
such assurance is not necessary, as determined by Agora) and not with a view to the distribution
thereof other than in compliance with the registration provisions of the Securities Act or any
exemption therefrom, and the Optionee shall give such other assurance and take such other action as
Agora shall require to secure compliance with any law, rule or regulation applicable to the
issuance of shares of Common Stock. Moreover, if at the time of Option exercise the Common Stock
is not Publicly Traded and the Optionee is so requested by the Company, in conjunction with
delivery by the Company of the shares of Common Stock, the Optionee shall enter into a stockholders
agreement by and between stockholders of Agora and Agora Company.

     7. Termination of Option. This Option and all rights of the Optionee to purchase
shares of Common Stock hereunder shall terminate on the tenth anniversary of the Option Grant Date
(the “Expiration Date”), unless terminated earlier in accordance with the terms hereof.

     8. Termination of Employment.

2

 

          (a) Termination of Employment for Cause. In the event that the Company terminates Optionee’s
employment for Cause (as defined in the Plan), the Option shall immediately terminate.

          (b) Death or Disability. In the event that the Optionee’s employment with the Company
terminates by reason of death or Disability (as defined in the Plan), (i) to the extent that
pursuant to Section 2 the Option is not vested on the Optionee’s last day of employment, the Option
shall expire, and (ii) to the extent that it is vested on the Optionee’s last day of employment,
the Option shall continue to be exercisable (but not beyond the Expiration Date) for a period of
one year following such termination.

          (c) Other Termination of Employment. In the event that the Optionee ceases to be an employee
of the Company for any reason other than as described in paragraphs (a) and (b) of this Section 8,
(i) to the extent that pursuant to Section 2 the Option is not vested on the Optionee’s last day of
employment, the Option shall expire, and (ii) to the extent that pursuant to Section 2 the Option
is vested on the Optionee’s last day of employment, the Option shall continue to be exercisable
(but not beyond the Expiration Date) until the date which is three (3) months from Optionee’s last
day of employment; provided, however, that in the event that the Optionee is subject to any
non-compete, non-solicitation or confidentiality agreement which he violates, the Option shall
immediately terminate upon such violation. Solely for purposes of this Section 8, if the Optionee
terminates employment with the Company and immediately thereafter becomes a consultant to the
Company pursuant to a written agreement which so specifies, the Optionee will be deemed to satisfy
the employment requirement of this Section 8 during the period of the Optionee’s consultancy.

     9. Notice. All notices, requests, demands, waivers and communications required or
permitted to be given hereunder shall be in writing and shall be delivered in person or mailed,
certified or registered mail with postage prepaid, or sent by facsimile, as follows:

	 	(a)	 	If to Agora or the Company, to it at:

Agora Media Inc.

45 Main Street, Suite 406

Brooklyn, New York 11201

Attention: Chief Executive Officer.

          (b) If to Optionee, to him or her at the address specified in the Issuance Sheet;

or to such other address as either party hereto shall specify by notice in writing to the other
party in accordance with this Section. In the case of mailing, all such notices, requests,
demands, waivers and communications shall be deemed to have been received on the third business day
after the date of the mailing.

     10. Adjustment. The number of shares of Common Stock subject to the Option and the
price per share of Common Stock shall be subject to adjustment, as set forth in the Plan. Agora
shall not be required to adjust the number of shares of Common Stock subject to

3

 

the Option or the price per share of Common Stock for any reason not specifically enumerated
in the Plan.

     11. No Stockholder Rights. The Optionee shall have no rights as a stockholder of
Agora with respect to shares of Common Stock subject to the Option until payment for such shares
shall have been made in full and until the date of the issuance of stock certificates for such
shares of Common Stock. If the Optionee pays the Option exercise price with shares of Common
Stock, the Optionee shall continue to be the stockholder of record with respect to the shares which
he or she has tendered as exercise payment until the Optionee becomes the holder of record of the
shares covered by the Option.

     12. No Employment Rights. Nothing herein contained shall restrict in any way the
right of the Company to terminate the Optionee’s employment at any time, with or without cause.

     13. Option Subject to Plan. The Optionee acknowledges receipt of a copy of the Plan.
The Option has been granted pursuant to the Plan and is in all respects subject to the terms and
conditions thereof. In the event of any conflict between this Agreement and the Plan, the terms of
the Plan shall control.

     14. Nontransferability.

          (a) Subject to paragraphs (b) and (c), the Option is not transferable, other than by will or
the laws of descent and distribution, and may be exercised, during the lifetime of the Optionee
only by the Optionee, or the Optionee’s guardian or legal representative. In the event of any
attempt by the Optionee to transfer, assign, pledge, hypothecate or otherwise dispose of the Option
or of any right hereunder, except as provided for herein, or in the event of the levy of any
attachment, execution or similar process upon the rights or interest hereby conferred, Agora may
terminate the Option by notice to the Optionee and it shall thereupon become null and void.

          (b) Notwithstanding paragraph (a), the Optionee may transfer the Option, by gift or a domestic
relations order, to a Family Member of the Optionee.

          (c) Notwithstanding paragraph (a) the Optionee may transfer the Option with the express,
written consent of the Board, which consent may be withheld for any reason or for no reason.

     15. Restrictions Applicable to Option Stock.

          (a) Agora’s Right of First Refusal. Before any shares of Common Stock delivered upon Option
exercise (“Shares”) may be transferred, assigned, pledged, hypothecated or otherwise disposed of
(including transfer by gift or operation of law) by the Optionee or any transferee (either being
sometimes referred to in this Section 15 as the “Holder”) (other than pursuant to Section 15(e)),
Agora or its assignee(s) shall have a right of first refusal to purchase the Shares on the terms
and conditions set forth in this Section 15(a) (the “Right of First Refusal”). Pursuant to the
Right of First Refusal, in the event that the Holder of the Shares intends to sell or otherwise
transfer the Shares, the Holder shall be required to deliver to Agora a

4

 

written notice (the “Notice”) stating: (i) the Holder’s bona fide intention to sell or
otherwise transfer such Shares; (ii) the name of each proposed purchaser or other transferee
(“Proposed Transferee”) and the proposed manner of transfer; (iii) the number of Shares to be
transferred to each Proposed Transferee; and (iv) the bona fide cash price or other consideration
for which the Holder proposes to transfer the Shares (the “Offered Price”), and the Holder shall
offer to sell the Shares at the Offered Price to Agora or its assignee(s). At any time within
thirty (30) days after receipt of the Notice, Agora and/or its assignee(s) may, by giving written
notice to the Holder, elect to purchase all, but not less than all, of the Shares proposed to be
transferred to any one or more of the Proposed Transferees, at the purchase price determined in
accordance with this Section 15(a). The purchase price (“Purchase Price”) for the Shares purchased
by Agora or its assignee(s) under this Section 15(a) shall be the Offered Price. If the Offered
Price includes consideration other than cash, the cash equivalent value of the non-cash
consideration shall be determined by the Board in good faith. Payment of the Purchase Price shall
be made, at the option of Agora or its assignee(s), in cash (by check), by cancellation of all or a
portion of any outstanding indebtedness of the Holder to Agora (or, in the case of repurchase by an
assignee, to the assignee), or by any combination thereof within thirty (30) days after receipt of
the Notice or in the manner and at the times set forth in the Notice. If all of the Shares
proposed in the Notice to be transferred to a given Proposed Transferee are not purchased by Agora
and/or its assignee(s) as provided in this Section 15(a), then the Holder may sell or otherwise
transfer such Shares to that Proposed Transferee at the Offered Price or at a higher price,
provided that such sale or other transfer is consummated within one hundred twenty (120) days after
the date of the Notice and provided further that any such sale or other transfer is effected in
accordance with any applicable securities laws and the Proposed Transferee agrees in writing that
the provisions of Sections 15 and 16 shall continue to apply to the Shares in the hands of such
Proposed Transferee. If the Shares described in the Notice are not transferred to the Proposed
Transferee within such period, a new Notice shall be given to Agora, and Agora and/or its assignees
shall again be offered the Right of First Refusal as provided herein before any Shares held by the
Holder may be sold or otherwise transferred. Any attempted transfer which is made in violation of
this paragraph shall be null and void and shall not be honored by Agora.

     Within one hundred twenty (120) days of receipt of the Notice, neither Agora nor the Optionee
may exercise their rights under Section 15(b).

     Anything to the contrary contained in this Section 15(a) notwithstanding, the transfer of any
or all of the Shares during the Optionee’s lifetime or on the Optionee’s death by will or intestacy
to a Family Member of the Optionee (as defined in the Plan) shall be exempt from the provisions of
this Section 15(a). In such case, the transferee or other recipient shall receive and hold the
Shares so transferred subject to the provisions of Sections 15 and 16, and there shall be no
further transfer of such Shares except in accordance with the terms of Sections 15 and 16.

          (b) Agora’s Repurchase Right. At any time after the later of (i) the date Optionee’s
employment with the Company has ended and (ii) the date six months after Optionee has acquired the
Shares, Agora shall have the right to repurchase from the Optionee or any Holder all or any portion
of the Shares pursuant to the terms of this Section 15(b). At the time that Agora exercises its
repurchase right hereunder, Agora shall pay to the Holder in cash

5

 

(or by cancellation of purchase money indebtedness) the Fair Market Value (as defined in the
Plan) of such Shares on such date.

          (c) Purchase of Shares. Any purchase by Agora of Shares and payment therefore pursuant to the
forgoing provisions of this Section 15 shall be against delivery of the certificate representing
the Shares to be purchased by Agora endorsed in blank or together with a stock power executed in
blank.

          (d) No Sales to Competitors. Shares shall not be transferable to competitors of the Company.
For purposes hereof, a person shall be considered to be a “competitor” if at such time it is
engaged in or has under development or is proposed to be engaged in one or more of the businesses
of the Company. The determination of whether a person is a competitor shall be made by the Board
in its sole discretion.

          (e) Drag-Along. If holders in the aggregate of more than 50% of the outstanding shares of
Common Stock of the Company, as one class (“Selling Stockholders”), propose to sell, assign,
mortgage, transfer, pledge, hypothecate or otherwise dispose of all, but not less than all, of
their respective shares to a third party in one or a series of related transactions which is
approved by a majority of the Board, then the Selling Stockholders may, at their option, require
the Holder to sell all of such Holder’s Shares in such transfer to the third party on the same
terms and conditions, and for the same consideration, as the Selling Stockholders. The Holder
shall take such necessary or desirable actions in connection with the consummation of such
transaction as reasonably requested by Agora or the Selling Stockholders.

          (f) Specific Performance. Due to the fact that the Shares cannot be readily purchased or sold
in the open market, and for other reasons, the Company and/or its existing stockholders may be
irreparably damaged in the event that Section 15 of this Agreement is not specifically enforced.
Consequently, in the event of a breach or threatened breach of the terms, covenants and/or
conditions of this Section 15, the Company shall, in addition to all other remedies, be entitled to
a temporary or permanent injunction, without showing any actual damage or posting a bond, and/or a
decree for specific performance, in accordance with the provisions hereof.

          (g) Termination. The restrictions and rights provided for in this Section 15 shall terminate
when the Common Stock becomes Publicly Traded (but shall not result in the acceleration of
installment payments which have commenced pursuant to paragraph (b)).

     16. Lock-Up Agreement. The Optionee agrees that in connection with an underwritten
public offering of Common Stock, upon the request of Agora or the principal underwriter managing
such public offering, shares of Common Stock acquired pursuant to the exercise of the Option (and
any shares of Common Stock received directly or indirectly with respect thereto) may not be sold,
offered for sale or similar financial effect or otherwise disposed of without the prior written
consent of Agora or such underwriter, as the case may be, for a period not exceeding one year after
the effectiveness of the registration statement filed in connection with such offering, but only to
the extent that Agora’s directors, executive officers and/or their immediate family are similarly
bound. The Optionee agrees to sign such further

6

 

documents as Agora may reasonably request to give this Section effect. The lock-up agreement
established pursuant to this Section 16 shall have perpetual duration.

     17. NSO. It is intended that this Option shall not constitute an incentive stock
option for purposes of Section 422 of the Internal Revenue Code of 1986, as amended.

     18. Board Determinations. In the event that any question or controversy shall arise
with respect to the nature, scope or extent of any one or more rights conferred by the Option, or
any provision of this Agreement, the determination by the Board (or the Committee established by
the Board to administer the Plan) of the rights of the Optionee shall be conclusive, final and
binding upon the Optionee and upon any other person who shall assert any right pursuant to this
Option.

     19. Jurisdiction; Venue. Each of Agora and Optionee irrevocably (i) agrees that any
suit, action or proceeding arising out of or relating to this Agreement may be brought in the State
or Federal courts located in The City of New York, County of New York; (ii) consents to the
exclusive jurisdiction of each such court in any suit, action or proceeding relating to or arising
out of this Agreement; (iii) waives any objection which it may have to the laying of venue in any
such suit, action or proceeding in any of such court; and (iv) agrees that service of any court
paper may be made in such manner as may be provided under applicable laws or court rules governing
service of process, including, without limitation, by the mailing of copies thereof by registered
or certified mail, postage pre-paid, to the other party at its address set forth in Section 9
hereof, such service to become effective five (5) business days after such mailing.

     20. Definitions. Any term contained in this Agreement which is defined in the Plan
but not defined herein shall have the meaning provided under the Plan.

     21. Issuance Sheet. The Issuance Sheet attached hereto is hereby incorporated by
reference. The General Provisions and the Issuance Sheet constitute a single Nonqualified Stock
Option Agreement under the Agora Media Inc. 2003 Stock Option Plan.

     22. Replacement of Prior Agreements. Except as otherwise explicitly provided in the
Issuance Sheet, this Agreement sets forth the entire understanding of the parties with respect to
the subject matter provided for herein, including, the grant of stock options and the terms
thereof, and supersedes any and all existing agreements between the parties concerning such subject
matter. The Optionee hereby waives any and all claims that may exist on the date this Agreement is
signed, including, but not limited to, contingent claims, arising from any oral or written
agreement between the parties, including, but not limited to, stock option provisions which may
appear in an employment agreement, which relate to the grant of or the terms of stock options and
all other subject matter provided for herein.

7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00226-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00226-of-00352.parquet"}]]